Transaction · 0001992352-26-000007

Guarini Kathryn

Guarini Kathryn, DIR, reported a transaction classified as exercise at REGENERON PHARMACEUTICALS, INC. involving 400.000000 shares for an estimated $287748.00. Reported holdings after the transaction were 1003.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MDIR
REGNREGENERON PHARMACEUTICALS, INC.
Trade date
Sep 02, 2026
Filing date
Sep 03, 2026
View on SEC Insider profile
Estimated value$287kShares × reported price
Shares traded400$719.37 per share
Holdings after1.00kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

REGN price since this filing

Daily closing prices, with the filing date and available return windows
REGN · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -10.0%1w ago -3.4%1d ago -2.3%
Returns since7d -6.0%30d -12.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001992352-26-000007
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 03, 2026, 08:47 PM · 1d delay
Shares
400 sh
$719.37 per share
Estimated value
$287k
Computed from shares × price
Holdings after
1,003 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2026.

  2. F2

    On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant…

Original filing · 0001992352-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

REGN